- ADVERTISEMENT
-
Most Popular
- ADVERTISEMENT
NSRGY
Pfizer to Spin Off Its Animal Health Biz
Pfizer announced Thursday its plan to spin off its animal health business into a stand-alone company named Zoetis.
Nestle: A Global Dividend Powerhouse
Nestle is a world wide brand name that produces products, earnings, and dividends at a remarkable rate every year. Nestle is a great portfolio buy.
4 Stocks Buffett May Be Buying in Europe
A look at the Oracle's buying behavior in the past clues you in to where his cash is likely being funneled now.
Mead Johnson: A Formula for Success
The maker of infant formula and pediatric products is a perpetual winner, with strong growth in foreign markets as well.
3 Acquisitions That Don’t Deliver the Goods
A recent study suggests acquisitions are a drag on the buying company's stock price. Here's a look at three examples of how M&A handiwork usually backfires.
How the Shorts Figured Out Green Mountain
GMCR sank by almost 40% after the bell Wednesday as the company cut its full-year earnings forecast. But several red flags preceded the report.
ETF Alternatives for Last Week’s Hot Stocks
This week we look at banks, toys, soda pop, baby food and the Web.
Feel Safe Scooping Up Swiss Stocks
There's a lot to like about Switzerland as an investment haven. It's not a perfect environment, but a number of Swiss stocks look promising right now.
3 Cures for the Summertime Market Blues
Prepare now for the typical doldrums with these warm-weather friends. They may not be the hottest things around, but they're likely to be steady.
Nestle Poised to Buy Pfizer’s Baby Formula
Several sources say Swiss food giant Nestle will win the bid for Pfizer's infant nutrition business.
Food Stocks: A Simple Yet Smart Investment
People need to eat, and we keep making people -- it's not a sexy investment thesis, but it can make you money. These stocks are in prime position to benefit.
GMCR, Watson Zoom on Deals — Wednesday’s IP Market Recap
Green Mountain gets a much-needed lift from Starbucks, and Watson is buying generic-drug maker Actavis.
Nestle’s CEO Sees Agricultural Output Rising
Chief Exec Paul Bulcke says higher food costs are spurring new investment in agricultural production. Good thing, because the world clearly needs more food.
Starbucks Verismo Brewer Might Sink Nestle as Well as GMCR
Starbucks NASDAQ:SBUX made a splash two weeks ago with the launch of its high-pressure Verismo coffee machine, which could hurt Nestle and its Nescafe business.
Breaking Down Societe Generale’s Top 40 Dividend Stocks in the World
Societe Generale recently put out its annual list of the top 40 dividend payers across the globe. Here's a look at those companies, as well as a few trends.
Why Starbucks Is Still Steaming Hot
Innovative products, improved customer service and new efforts in Europe and India should keep the java giant growing for years to come.
Can the Average Investor Cash in on the Latest Mergers?
Owning a stock involved in a merger or acquisition is a lot like winning the lottery. Find out how you can stack the odds in your favor.
5 Foreign Dividend Strongholds to Buy
If your portfolio is living and dying by growth, the global economy might zing you. Protect yourself with these five foreign dividend strongholds.
Valentine’s Day Stocks: Anything to Love?
Take a look at companies that make the holiday -- purveyors of chocolate, diamonds and flowers -- to see if you would do well to take a shine to them.
